Danaher Co. (NYSE:DHR) Shares Bought by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 7.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 63,534 shares of the conglomerate's stock after buying an additional 4,388 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Danaher were worth $14,584,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Heck Capital Advisors LLC purchased a new stake in shares of Danaher during the fourth quarter worth approximately $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher in the 4th quarter valued at $31,000. Golden State Wealth Management LLC purchased a new position in Danaher during the 4th quarter worth $31,000. Hurley Capital LLC acquired a new position in shares of Danaher during the fourth quarter worth about $34,000. Finally, Pineridge Advisors LLC raised its holdings in Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after purchasing an additional 57 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Stock Up 0.1%

NYSE DHR traded up $0.22 on Monday, reaching $196.33. The company had a trading volume of 2,724,501 shares, compared to its average volume of 3,451,187. Danaher Co. has a 1 year low of $171.00 and a 1 year high of $281.70. The firm has a market capitalization of $140.51 billion, a PE ratio of 37.18, a P/E/G ratio of 2.66 and a beta of 0.80. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The firm has a 50-day moving average of $196.87 and a 200-day moving average of $217.27.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The business had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. On average, equities research analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.65%. Danaher's dividend payout ratio is presently 24.85%.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Barclays boosted their target price on Danaher from $205.00 to $215.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 22nd. Stifel Nicolaus upgraded Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective for the company in a research report on Friday, March 14th. Jefferies Financial Group reduced their target price on Danaher from $260.00 to $230.00 and set a "buy" rating for the company in a report on Tuesday, April 22nd. Robert W. Baird decreased their price target on Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Finally, Wells Fargo & Company lowered their price objective on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a research note on Thursday, January 30th. Four research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $264.40.

Insider Transactions at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president now directly owns 15,179 shares in the company, valued at $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the sale, the chairman now directly owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.